Weekly Recap | IBM -0.3%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.IBM (IBM) fell 0.3% this week to close at $234.89, while the S&P 500 added 0.09%, leaving the stock about 0.39 percentage points behind the benchmark. The week was mostly a choppy one: Monday opened at $232.73 and closed at $233.87, Tuesday and Wednesday drifted lower with an intraday low of $229.10, Thursday climbed to a week high of $238.29, and Friday settled back at $234.89. Weekly amplitude was 3.95%. Average daily volume of 4.42 million shares came in roughly 38.
The Week
IBM (IBM) fell 0.3% this week to close at $234.89, while the S&P 500 added 0.09%, leaving the stock about 0.39 percentage points behind the benchmark. The week was mostly a choppy one: Monday opened at $232.73 and closed at $233.87, Tuesday and Wednesday drifted lower with an intraday low of $229.10, Thursday climbed to a week high of $238.29, and Friday settled back at $234.89. Weekly amplitude was 3.95%. Average daily volume of 4.42 million shares came in roughly 38.46% below the 60-day median, pointing to subdued turnover.
Key Events
The most company-specific headline this week was IBM Ventures investing in BQP, whose quantum-algorithm physics acceleration has reached production stage. IBM also backed model routing as a way to steer AI workloads across providers when costs and performance shift, extending its AI infrastructure push. Several institutions disclosed position changes in IBM: Simplicity Wealth LLC made a new $8.35 million investment, Commerzbank AG and Diversify Advisory Services LLC bought new shares, while Calamos Advisors LLC trimmed its holdings. IBM was also flagged among Dow Jones Industrial Average dividend winners with a yield of 2.9% or more. Related industry news included ASUS expanding AI infrastructure collaboration with Intel and AMD, and commentary on India’s quantum technology journey, both echoing the AI and quantum themes tied to IBM.
Analyst Ratings
Across 26 covering institutions, 10 rate IBM a buy and 3 rate it overweight, 10 call it a hold, while 1 rates it underweight and 1 rates it sell; 1 has no opinion. The consensus recommendation is buy, with a consensus target price of $245.35, about 4.45% above the spot price of $234.89. The target range spans from $174 to $350, a wide gap that reflects notable disagreement among analysts. Within the IT consulting industry, IBM ranks third out of 35 companies covered.
The Week Ahead
The macro calendar is fairly busy next week: US NFIB small business optimism is due on Tuesday, 9 September, followed on Thursday, 10 September by initial jobless claims, final demand PPI, existing home sales annual rate, wholesale sales, and 10-year Treasury auction results. On the company side, IBM’s fiscal Q3 2026 results are scheduled for an after-market release much later, on Wednesday, 21 October.
In Short
IBM’s share price was mostly range-bound this week, with a limited decline and low volume suggesting the market did not make a strong directional call. Company-level news centred on AI and quantum computing progress, while the S&P 500 moved slightly higher and IBM lagged by a small margin. The analyst picture leans constructive: consensus is a buy and the consensus target sits above spot, though the wide target range signals that pricing expectations remain split. The key things to watch are next week’s dense run of US macro data and whether it shifts the valuation backdrop for tech blue chips, as well as the approaching date of IBM’s next quarterly disclosure.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.